Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 03, 2026
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Thursday, 24'th Jul 2025
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Wall Street Analysts Think Exact Sciences (EXAS) Could Surge 26.24%: Read This Before Placing a Bet
10:56am, Tuesday, 15'th Jul 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 26.2% in Exact Sciences (EXAS). While the effectiveness of this highly sought-after metric is questionable, the
Exact Sciences Schedules Second Quarter 2025 Earnings Call
06:00am, Monday, 14'th Jul 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2
QGEN or EXAS: Which Is the Better Value Stock Right Now?
12:40pm, Thursday, 10'th Jul 2025
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Qiagen (QGEN) or Exact Sciences (EXAS). But which of these two stocks presents investors with
Geneoscopy Wins Patent Trial and Appeal Board Decision, Invalidating All 20 Claims of Exact Sciences' '781 Patent
11:19am, Thursday, 10'th Jul 2025
ST. LOUIS, Mo.--(BUSINESS WIRE)--Geneoscopy wins PTAB ruling as all 20 claims of Exact Sciences' '781 patent are invalidated, paving the way for continued advancement of ColoSense.
Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer
06:00am, Wednesday, 09'th Jul 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that its Oncodetect™ molecular residual disease (MRD
What Makes Exact Sciences (EXAS) a New Buy Stock
01:01pm, Monday, 07'th Jul 2025
Exact Sciences (EXAS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
QGEN vs. EXAS: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 24'th Jun 2025
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Qiagen (QGEN) and Exact Sciences (EXAS). But which of these two stocks offers value investors a better bang fo
Should You Continue to Hold EXAS Sciences Stock in Your Portfolio?
09:55am, Thursday, 05'th Jun 2025
EXAS rides on strong Cologuard and Oncotype DX growth, but rising costs and high debt may test its staying power.
Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap
06:05am, Wednesday, 28'th May 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced new data to be presented from the Beta-CORRECT clinica
Exact Sciences to Participate in June Investor Conference
04:05pm, Tuesday, 27'th May 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the follow
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025
05:05pm, Thursday, 22'nd May 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it will present ten abstracts at the 2025 American Soc
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years
04:51am, Wednesday, 14'th May 2025
While being an innovative company doesn't guarantee superior long-term returns, it doesn't hurt those chances either. In fact, when a corporation is making important breakthroughs and boasts significa
Exact Sciences Earns 2025 Great Place To Work® Certification™
10:00am, Monday, 12'th May 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today that it has been certified as a 2025 Great Place To Work® f
Exact Sciences Q1 Earnings: Decent Quarter, But Growth Story Not Compelling
12:52pm, Friday, 02'nd May 2025
Exact Sciences Corporation posted solid Q1 2025 earnings with revenues up 11% year-on-year, driven by strong performance in screening and Precision Oncology segments. Despite the sequential revenue de
